CHI3L1 and asthma: Studies have shown that serum YKL-40 level is increased in patients with asthma and correlated with asthma severity, thickness of the subepithelial basement membrane, and pulmonary function, indicating that serum YKL-40 is an inflammatory biomarker associated with disease activity and mortality in asthmatic patients [12, 26].